University of California San Francisco

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (29990500)

Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC PMID: 29990500

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (29990500)

Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC PMID: 29990500

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (29990500)

Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC PMID: 29990500

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (29990500)

Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC PMID: 29990500

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (29990500)

Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC PMID: 29990500

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (29990500)

Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, Ruben B, North J, Pincus L, Yeh I, Judson R, Bastian BC PMID: 29990500

Topical timolol: An effective treatment option for agminated pyogenic granuloma. (29961974)

McGinness A, Gillam A, Yeh I, Mathes EF PMID: 29961974

Topical timolol: An effective treatment option for agminated pyogenic granuloma. (29961974)

McGinness A, Gillam A, Yeh I, Mathes EF PMID: 29961974

Progressive Hyperpigmented Plaques.

Kristen M. Beck, Jeffrey P. North, Tina Bhutani PMID:

Clinical Usefulness of Imaging and Blood Cultures in Cellulitis Evaluation. (29610842)

Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Dobry AS, Kroshinsky D PMID: 29610842